Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ainos Inc
(NQ:
AIMD
)
0.6400
-0.0060 (-0.93%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Ainos Inc
< Previous
1
2
Next >
Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety
August 19, 2024
Via
ACCESSWIRE
Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024
August 12, 2024
Via
ACCESSWIRE
Ainos Secures Exclusive Multi-Regions Invention Patent Licenses from Strategic Partner to Bolster AI Nose and Point-Of-Care Testing
August 09, 2024
Via
ACCESSWIRE
Ainos Concludes Growth Financing From Lind Partners
August 06, 2024
Via
ACCESSWIRE
Ainos Reports Second Quarter 2024 Financial Results
August 05, 2024
Via
ACCESSWIRE
Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug
July 23, 2024
Via
ACCESSWIRE
Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA
June 13, 2024
Via
ACCESSWIRE
Ainos Reports First Quarter 2024 Financial Results
May 13, 2024
Via
ACCESSWIRE
Ainos Raises $9 Million in Growth Capital with Existing Shareholder
May 07, 2024
Via
ACCESSWIRE
Ainos Reports Full Year 2023 Financial Results
March 08, 2024
Via
ACCESSWIRE
Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market
May 15, 2024
Via
ACCESSWIRE
Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing
February 08, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Small-Cap Growth Virtual Investor Conference Agenda Announced for February 7th, 2024
February 06, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Ainos Announces $1.75 Million Follow-On Funding
January 24, 2024
Via
ACCESSWIRE
Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical
November 28, 2023
Via
ACCESSWIRE
Ainos Reports Third Quarter 2023 Financial Results
November 09, 2023
Via
ACCESSWIRE
Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms
February 05, 2024
Via
ACCESSWIRE
Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th
February 01, 2024
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement
January 02, 2024
Via
ACCESSWIRE
Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell
December 26, 2023
Via
ACCESSWIRE
Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement
September 25, 2023
Via
ACCESSWIRE
Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan
September 05, 2023
Via
ACCESSWIRE
Ainos Reports Second Quarter 2023 Financial Results
August 11, 2023
Via
ACCESSWIRE
Ainos, Inc. Announces Stock Consolidation
December 12, 2023
Via
ACCESSWIRE
Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA
November 21, 2023
Via
ACCESSWIRE
With Orphan Drug Designation, Ainos' VELDONA Has Compelling Opportunity to Improve Quality of Life for HIV Patients
September 19, 2023
Boston, Massachusetts--(Newsfile Corp. - September 19, 2023) - The U.S. Food and Drug Administration (FDA) has granted Ainos' (NASDAQ:...
Via
Newsfile
Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients
September 18, 2023
Via
ACCESSWIRE
Ainos, Inc - The AI Nose "Knows" What's Inside Your Body and Beyond
August 15, 2023
Boston, Massachusetts--(Newsfile Corp. - August 15, 2023) - Here at Horizon Insights, we see...
Via
Newsfile
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ainos Celebrates First Listing Anniversary on Nasdaq
August 10, 2023
Via
ACCESSWIRE
Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry Adoption
August 09, 2023
Via
ACCESSWIRE
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.